Skip to main content

ORIGINAL RESEARCH article

Front. Pharmacol., 16 October 2018
Sec. Ethnopharmacology
Volume 9 - 2018 | https://doi.org/10.3389/fphar.2018.01180

RETRACTED: Icariin Ameliorates Palmitate-Induced Insulin Resistance Through Reducing Thioredoxin-Interacting Protein (TXNIP) and Suppressing ER Stress in C2C12 Myotubes

Retracted

A retraction of this article was approved in:

  1. Retraction: Icariin ameliorates palmitate-induced insulin resistance through reducing thioredoxin-interacting protein (TXNIP) and suppressing ER stress in C2C12 myotubes

    1. Read retraction
\r\nMingxin LiMingxin LiYemin ZhangYemin ZhangYingkang CaoYingkang CaoDeling ZhangDeling ZhangLe LiuLe LiuYanghongyun GuoYanghongyun GuoChanghua Wang*Changhua Wang*
  • Department of Pathology and Pathophysiology, Wuhan University School of Basic Medical Sciences, Wuhan, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Li M, Zhang Y, Cao Y, Zhang D, Liu L, Guo Y and Wang C (2018) Icariin Ameliorates Palmitate-Induced Insulin Resistance Through Reducing Thioredoxin-Interacting Protein (TXNIP) and Suppressing ER Stress in C2C12 Myotubes. Front. Pharmacol. 9:1180. doi: 10.3389/fphar.2018.01180

Received: 15 July 2018; Accepted: 28 September 2018;
Published: 16 October 2018; Retracted: 06 October 2023.

Edited by:

Karl Tsim, Hong Kong University of Science and Technology, Hong Kong

Reviewed by:

Yu Chen, National Institutes of Health (NIH), United States
Mingyu Li, Xiamen University, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.